glp 1 drug coverage How many adults with private health insurance could use GLP-1 drugs GLP-1s and The Payer Predicament
Description
2017;313:E651E662
The mechanism is straightforward: GLP-1 RAs enhance glucose-dependent insulin secretion, and stacking that on top of glucose-independent insulin release from exogenous insulin or sulfonylureas removes the glucose-dependent safety brake
For GLP-1 RAs, none of the simulations produced a cost-effective ICER in either population
Thats probably the biggest thing I hear from people [taking GLP-1s]: I dont think about food all day long, Eliszewski says
It uses natural bioactive peptides and polyphenols, delivered orally as a nutraceutical, primarily for fat loss and appetite control
Participants lost up to 13.1% of their body weight on Mounjaro 15 mg, versus 6.7% with semaglutide
